| Filed On | Filing |
|---|---|
| 03 Jun 2025 |
Form 4: Vittiglio Joseph, Chief Business & Legal Officer
Disposed of 1,143 shares (Tender Offer) · Returned 5,625 shares to the issuer · Received 2,500 shares as a grant or award |
| 03 Jun 2025 |
Form 4: Agwunobi John O, Director
Disposed of 1,323 shares (Tender Offer) · Returned 1,245 shares to the issuer |
| 03 Jun 2025 |
Form 4: Vachon Mark, Director
Disposed of 1,252 shares (Tender Offer) · Returned 1,245 shares to the issuer |
| 03 Jun 2025 |
Form 4: Colvin Richard A, Chief Medical Officer
Disposed of 3,552 shares (Tender Offer) · Returned 6,666 shares to the issuer · Received 2,500 shares as a grant or award |
| 03 Jun 2025 |
Form 4: Tita-Reid Najoh, Director
Disposed of 1,163 shares (Tender Offer) · Returned 1,245 shares to the issuer |
| 03 Jun 2025 |
Form 4: Obenshain Andrew, Director
Disposed of 9,027 shares (Tender Offer) · Returned 24,120 shares to the issuer · Received 14,820 shares as a grant or award |
| 03 Jun 2025 |
Form 4: Leiderman Elisabeth, Director
Disposed of 1,112 shares (Tender Offer) · Returned 1,245 shares to the issuer |
| 03 Jun 2025 |
Form 4: Jones-Burton Charlotte, Director
Disposed of 928 shares (Tender Offer) · Returned 1,245 shares to the issuer |
| 03 Jun 2025 |
Form 4: Klima Thomas J, See Remarks
Disposed of 3,414 shares (Tender Offer) · Returned 6,964 shares to the issuer · Received 2,500 shares as a grant or award |
| 03 Jun 2025 |
Form 4: Sterling O. James, Chief Financial Officer
Returned 7,500 shares to the issuer · Received 2,500 shares as a grant or award |
| 03 Jun 2025 |
Form 4: Leschly Nick, Director
Disposed of 22,850 shares (Tender Offer) · Returned 1,245 shares to the issuer |
| 03 Jun 2025 |
Form 4: Paulson Richard A., Director
Disposed of 155 shares (Tender Offer) · Returned 1,323 shares to the issuer |
| 03 Jun 2025 |
Form 4: Cloonan Michael, Director
Returned 1,867 shares to the issuer |
| 05 Mar 2025 |
Form 4: Colvin Richard A, Chief Medical Officer
Sold 584 shares ($2.29K) |
| 05 Mar 2025 |
Form 4: Klima Thomas J, See Remarks
Sold 500 shares ($1.96K) |
| 05 Mar 2025 |
Form 4: Obenshain Andrew, Director
Sold 921 shares ($3.61K) |
| 12 Feb 2025 |
Form 4: Obenshain Andrew, Director
Received 763 shares as a grant or award |
| 05 Feb 2025 |
Form 4: Klima Thomas J, See Remarks
Sold 122 shares ($902) |
| 05 Feb 2025 |
Form 4: Colvin Richard A, Chief Medical Officer
Sold 64 shares ($473) |
| 05 Feb 2025 |
Form 4: Vittiglio Joseph, Chief Business & Legal Officer
Sold 238 shares ($1.76K) |
Loading...